| Metric | Q1 FY27 | Q4 FY26 | Q1 FY26 |
|---|---|---|---|
| Revenue from operations | 891.5 | 941.3 | 937.0 |
| Other income | 9.4 | 12.5 | 7.7 |
| Total income | 900.9 | 953.8 | 944.7 |
| Profit before exceptional items & tax | 169.6 | 218.1 | 264.7 |
| Profit before tax | 169.6 | 218.1 | 264.7 |
| Net profit | 126.3 | 153.1 | 192.1 |
| Operating margin | 18.8% | 22.9% | 28.0% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Net profit, year on year | -34.30% |
|---|---|
| Net profit, quarter on quarter | -17.50% |
| Revenue, year on year | -4.90% |
| Operating profit, year on year | -36.60% |
| Operating profit, quarter on quarter | -16.90% |
BSE results filing, NSE: PGHH. Figures extracted from the filing.
Procter & Gamble Hygiene & Healthcare Ltd: key numbers
- Share price
- ₹7,037.50
- Market cap
- ₹22,844 Cr
- Revenue (annual)
- ₹4,290 Cr
- Net profit (annual)
- ₹856.5 Cr
- P/E (TTM)
- 28.9×Sector 43.4×
- Promoter holding
- 70.64%+0.00% QoQ
- FII holding
- 0.98%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Procter & Gamble Hygiene & Healthcare Ltd
All →Procter & Gamble Hygiene & Healthcare Board Meeting Date
P&G Hygiene and Health Care will hold a board meeting on November 12, 2026, to consider unaudited standalone financial results for the half-year ending September 2026.
Procter & Gamble Hygiene & Healthcare Management Change
Procter & Gamble Hygiene and Health Care Limited has appointed Ms. Flavia Machado as Company Secretary and Compliance Officer, effective September 29, 2026.
Procter & Gamble Hygiene & Healthcare Price Movement Clarification
P&G Hygiene and Health Care denied baseless rumors of potential delisting or winding up. Filed under Reg 30(11) due to material price movement.
Procter & Gamble Hygiene & Healthcare Management Change
P&G Hygiene and Health Care announced appointment of Ms. Srividya Srinivasan as Whole-time Director effective July 1, 2026. Shareholders approved the five-year term at the 62nd AGM on September 8, 2026.
Procter & Gamble Hygiene & Healthcare Annual General Meeting
Procter & Gamble Hygiene and Health Care Ltd held its 62nd Annual General Meeting on September 8, 2026, to discuss financial statements, dividends, and director appointments.
Procter & Gamble Hygiene & Healthcare Earnings Call: Key Takeaways
P&G Hygiene reported FY26 sales of ₹4300cr (flat YoY) and PAT of ₹850cr (up 19%). Strategy focuses on 'irresistible superiority' in Feminine Care and Healthcare through innovation and productivity.